Skip Navigation LinksHome > October 2007 - Volume 7 - Issue 5 > Future directions in therapeutic interventions for conjuncti...
Current Opinion in Allergy & Clinical Immunology:
doi: 10.1097/ACI.0b013e3282ef69e3
Eye allergy

Future directions in therapeutic interventions for conjunctival inflammatory disorders

Pflugfelder, Stephen Ca; Stern, Michael Ea,b

Collapse Box


Purpose of review: To review recent advances in pathogenesis and treatment of conjunctival inflammatory disorders.

Recent findings: The conjunctiva becomes inflamed in a number of conditions, including allergy, atopy, dry eye, mucus membrane pemphigoid, Stevens-Johnson syndrome and surgical manipulation. Basic and clinical studies have identified a number of inflammatory mediators as potential therapeutic targets in these conditions. Additionally, new therapeutic agents and enhanced delivery systems have been evaluated.

Summary: Increased understanding of the key mediators of conjunctival inflammation coupled with improved drug delivery methods are leading to more effective therapy for conjunctival inflammatory disorders.

© 2007 Lippincott Williams & Wilkins, Inc.


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.